Stable mometasone furoate cream and preparation method thereof
The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean l...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YUAN LIXING CHENG LU DAI XIAOHUA ZHU KEXU WANG HAO LIU XIAOQIONG |
description | The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116421549A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116421549A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116421549A3</originalsourceid><addsrcrecordid>eNrjZLALLklMyklVyM3PTS1JLM7PS1VIKy3KTyxJVUguSk3MVUjMS1EoKEotSCxKLMnMz1MAKsvIT1EoyUgtSs1P42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoZmJkaGpiaWjsbEqAEAfT4w3g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Stable mometasone furoate cream and preparation method thereof</title><source>esp@cenet</source><creator>YUAN LIXING ; CHENG LU ; DAI XIAOHUA ; ZHU KEXU ; WANG HAO ; LIU XIAOQIONG</creator><creatorcontrib>YUAN LIXING ; CHENG LU ; DAI XIAOHUA ; ZHU KEXU ; WANG HAO ; LIU XIAOQIONG</creatorcontrib><description>The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230714&DB=EPODOC&CC=CN&NR=116421549A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230714&DB=EPODOC&CC=CN&NR=116421549A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YUAN LIXING</creatorcontrib><creatorcontrib>CHENG LU</creatorcontrib><creatorcontrib>DAI XIAOHUA</creatorcontrib><creatorcontrib>ZHU KEXU</creatorcontrib><creatorcontrib>WANG HAO</creatorcontrib><creatorcontrib>LIU XIAOQIONG</creatorcontrib><title>Stable mometasone furoate cream and preparation method thereof</title><description>The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLALLklMyklVyM3PTS1JLM7PS1VIKy3KTyxJVUguSk3MVUjMS1EoKEotSCxKLMnMz1MAKsvIT1EoyUgtSs1P42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoZmJkaGpiaWjsbEqAEAfT4w3g</recordid><startdate>20230714</startdate><enddate>20230714</enddate><creator>YUAN LIXING</creator><creator>CHENG LU</creator><creator>DAI XIAOHUA</creator><creator>ZHU KEXU</creator><creator>WANG HAO</creator><creator>LIU XIAOQIONG</creator><scope>EVB</scope></search><sort><creationdate>20230714</creationdate><title>Stable mometasone furoate cream and preparation method thereof</title><author>YUAN LIXING ; CHENG LU ; DAI XIAOHUA ; ZHU KEXU ; WANG HAO ; LIU XIAOQIONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116421549A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YUAN LIXING</creatorcontrib><creatorcontrib>CHENG LU</creatorcontrib><creatorcontrib>DAI XIAOHUA</creatorcontrib><creatorcontrib>ZHU KEXU</creatorcontrib><creatorcontrib>WANG HAO</creatorcontrib><creatorcontrib>LIU XIAOQIONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YUAN LIXING</au><au>CHENG LU</au><au>DAI XIAOHUA</au><au>ZHU KEXU</au><au>WANG HAO</au><au>LIU XIAOQIONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Stable mometasone furoate cream and preparation method thereof</title><date>2023-07-14</date><risdate>2023</risdate><abstract>The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN116421549A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Stable mometasone furoate cream and preparation method thereof |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T20%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YUAN%20LIXING&rft.date=2023-07-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116421549A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |